Overview of Dr. Sternberg
Dr. Cora Sternberg is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 39 years. She is one of 375 doctors at New York-Presbyterian Hospital and one of 119 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She also speaks multiple languages, including Italian. She has more than 100 publications and over 500 citings.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1978 - 1981
Perelman School of Medicine at the University of PennsylvaniaClass of 1978
Certifications & Licensure
CA State Medical License 1979 - Present
NY State Medical License 1978 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer Start of enrollment: 1998 Sep 01
- Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium Start of enrollment: 2001 Oct 01
- Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate Start of enrollment: 2004 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study.Petros Grivas, Pedro Barata, Helen Moon, Shilpa Gupta, Thomas Hutson
Clinical Genitourinary Cancer. 2024-12-01 - Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale.Cora N Sternberg, Stephen J Freedland, Daniel J George, Alicia K Morgans
Clinical Genitourinary Cancer. 2024-12-01 - Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists.Arnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, Dany Habr, Jochen Walz
Urology Practice. 2024-11-07
Journal Articles
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaCora N Sternberg, Jeanny B Aragon-Ching, Daniel P Petrylak, Petros Grivas, The New England Journal of Medicine
Other
- Adjuvant chemotherapy for muscle invasive urothelial (transitional cell) carcinoma of the bladderSternberg CN, Bellmunt J, Rosenberg JE
http://www.uptodate.com/contents/adjuvant-chemotherapy-for-muscle-invasive-urothelial-transitional-c
UpToDate, Wolters Kluwer Health - 2013-02-19
Press Mentions
How a Novel Genomic Analysis Leveraged Whole-Exome and RNA Sequencing to Save the Life of an Elderly PatientJuly 16th, 2024- ASCO GU 2021: PI3K/AKT Pathway Biomarkers Analysis from the Phase III IPATential150 Trial of Ipatasertib plus Abiraterone in Metastatic Castration-Resistant Prostate CancerFebruary 12th, 2021
- Current Treatment Approaches in Advanced Urothelial Carcinoma - Shilpa GuptaSeptember 8th, 2020
- Join now to see all
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
